-
MedicineNet.com - Wed Dec 2, 4:28 pm ET
Title: Stem Cells Repair Heart Attack Damage Category: Health News Created: 12/2/2009 10:20:00 AM Last Editorial Review: 12/2/2009 10:20:07 AM
-
San Jose Mercury News - Wed Dec 2, 5:19 pm ET
Today: Google to let news providers strengthen pay walls. Stem cell companies' shares soar after approval of tax-funded research. Federal Reserve issues upbeat economic assessment. Unemployment in October in most metro areas worsened or was flat. AT&T drops suit against Verizon and its ads.
-
San Francisco Chronicle - Wed Dec 2, 3:24 pm ET
Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions. The news from the National Institutes of Health should... Stem cell - Biotechnology - Stem cell line - Barack Obama - Government
-
UPI - Wed Dec 2, 1:43 pm ET
WASHINGTON, Dec. 2 (UPI) -- The U.S. National Institutes of Health announced approval Wednesday of the use of human embryonic stem cells in NIH-funded research.
-
Indie Research via Yahoo! Finance - Wed Dec 2, 2:23 pm ET
A major breakthrough for stem cell research sent stocks soaring on Wednesday.
-
Fox News - Wed Dec 2, 1:31 pm ET
NIH Approves 13 Embryonic Stem Cell Lines for Harvesting
-
The News-Press - Wed Dec 2, 1:54 pm ET
Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines...
-
Newswise - Wed Dec 2, 9:33 pm ET
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
-
Bloomberg - Wed Dec 2, 2:11 pm ET
The newly approved lines were created by researchers at Harvard University, in Cambridge, Massachusetts, and Rockefeller University, in New York, using private donations during the eight years that federal funding for stem-cell research was restricted by former President George W. Bush . The approval of the lines was announced today by Francis Collins , director of the National Institutes of ...
-
MedCity News - Wed Dec 2, 3:06 pm ET
Updated 6:11 p.m. BETHESDA, Maryland -- The National Institutes of Health has approved the first 13 lines of embryonic stem cells for use by federal researchers, ushering in a new era of research that is both promising and controversial. The Wednesday move by the NIH is the first fruit of an executive order by President Barack Obama that revoked a ban on using stem cells derived from embryonic ...
-
The Staunton News Leader - Thu Dec 3, 3:15 am ET
National Institutes of Health chief Francis Collins, a Staunton native, on Wednesday announced the first 13 human embryonic stem cell "lines" approved for federal research funding, under new rules put forward by the Obama administration this year.
-
EurekAlert! - Wed Dec 2, 5:36 pm ET
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the Dec. 8 issue of the Journal of the American College of Cardiology. Rush University Medical Center was the only Illinois site and one of 10 cardiac centers across the country that participated in the 53-patient, double-blind, placebo-controlled Phase I trial. Rush ...
-
Discovery Channel - Wed Dec 2, 3:45 pm ET
Having a variety of stem cell lines available could help researchers treat a variety of diseases and conditions.
-
Nasdaq - Wed Dec 2, 3:33 pm ET
WASHINGTON -(Dow Jones)- National Institutes of Health Director Francis S. Collins said the agency has approved 13 human embryonic stem cell lines for research that were created in a manner that was "beyond reproach" and "ethically defensible."
-
Pittsburgh Tribune-Review - Wed Dec 2, 10:24 pm ET
The Obama administration approved Wednesday the first human-embryonic stem cells for experiments by federally funded scientists under a new policy designed to dramatically expand government support for one of the most promising -- but also most contentious -- fields of biomedical research.